Serum Institute to soon launch cervical cancer vaccine
Serum Institute of India (SII) CEO Adar Poonawalla has said that India’s first indigenously developed quadrivalent Human Papilloma Virus (qHPV) vaccine ...
Serum Institute of India (SII) CEO Adar Poonawalla has said that India’s first indigenously developed quadrivalent Human Papilloma Virus (qHPV) vaccine ...
Bengaluru: Biocon Biologics Ltd (BBL), the material subsidiary of Biocon Limited has merged with Serum Institute of India’s wholly-owned subsidiary ...
New Delhi: Even as the countrywide vaccination is underway in India, the Serum Institute of India (SII) is working on ...